Testosterone and reward prediction-errors in healthy men and men with schizophrenia

Schizophrenia Research

Volumn 168, Issue 3, 2015, Pages 649-660

  Morris, R W ^a,b,c   Purves Tyson, T D ^a,b,c   Weickert, C Shannon ^a,b,c   Rothmond, D ^a,b,c   Lenroot, R ^a,b,c   Weickert, T W ^a,b,c  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b Schizophrenia Research Institute   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Androgen receptor; Associative learning; Midbrain; Postmortem; Reward; Schizophrenia; Sex hormones; Testosterone; Tyrosine hydroxylase; Ventral striatum

Indexed keywords

ANDROGEN RECEPTOR; CHLORPROMAZINE; DOPAMINE; MESSENGER RNA; PROLACTIN; TESTOSTERONE; TYROSINE 3 MONOOXYGENASE; OXYGEN;

ADULT; ANALYTICAL ERROR; ARTICLE; CLINICAL ARTICLE; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEARNING; LIGAND BINDING; MALE; MESENCEPHALON; MOTIVATION; POLYMERASE CHAIN REACTION; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REWARD; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TESTOSTERONE BLOOD LEVEL; VENTRAL STRIATUM; ANTICIPATION; BLOOD; BRAIN; BRAIN CIRCULATION; CHRONIC DISEASE; COHORT ANALYSIS; METABOLISM; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOSIS;

ADULT; ANTICIPATION, PSYCHOLOGICAL; BRAIN; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; COHORT STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PSYCHOTIC DISORDERS; RECEPTORS, ANDROGEN; REWARD; RNA, MESSENGER; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TESTOSTERONE; TYROSINE 3-MONOOXYGENASE;

EID: 84946479715     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.06.030     Document Type: Article

References (42)

1. Akhondzadeh S., Rezaei F., Larijani B., Nejatisafa A.A., Kashani L., Abbasi S.H. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophr. Res. 2006, 84:405-410.
2. Alexander G.M., Packard M.G., Hines M. Testosterone has rewarding affective properties in male rats: implications for the biological basis of sexual motivation. Behav. Neurosci. 1994, 108:424-428.
3. Archer J. Testosterone and human aggression: an evaluation of the challenge hypothesis. Neurosci. Biobehav. Rev. 2006, 30:319-345.
4. Bollini P., Pampallona S., Nieddu S., Bianco M., Tibaldi G., Munizza C. Indicators of conformance with guidelines of schizophrenia treatment in mental health services. Psychiatr. Serv. 2008, 59:782-791.
5. Coates J.M., Herbert J. Endogenous steroids and financial risk taking on a London trading floor. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6167-6172.
6. D'Ardenne K., McClure S.M., Nystrom L.E., Cohen J.D. BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 2008, 319:1264-1267.
7. de Beun R., Jansen E., Slangen J.L., Van de Poll N.E. Testosterone as appetitive and discriminative stimulus in rats: sex- and dose-dependent effects. Physiol. Behav. 1992, 52:629-634.
8. de Souza Silva M., Mattern C., Topic B., Buddenberg T., Huston J. Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone. Eur. Neuropsychopharmacol. 2009, 19:53-63. (Epub 2008 Sep 2024).
9. First M.B., Spitzer R.L., Gibbon Miriam, Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Patient Edition 2007, Biometrics Research Department, New York State Psychiatric Institute, New York, NY. 1st Revision Edition.
10. Hermans E.J., Bos P.A., Ossewaarde L., Ramsey N.F., Fernandez G., van Honk J. Effects of exogenous testosterone on the ventral striatal BOLD response during reward anticipation in healthy women. Neuroimage 2010, 52:277-283.
11. Juckel G., Schlagenhauf F., Koslowski M., Wustenberg T., Villringer A., Knutson B., Wrase J., Heinz A. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 2006, 29:409-416.
12. Kanayama G., Brower K.J., Wood R.I., Hudson J.I., Pope H.G. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction 2009, 104:1966-1978.
13. Kanayama G., Hudson J.I., Pope H.G. Illicit anabolic-androgenic steroid use. Horm. Behav. 2010, 58:111-121.
14. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
15. Knutson B., Gibbs S.E. Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology 2007, 191:813-822.
16. Ko Y.H., Jung S.W., Joe S.H., Lee C.H., Jung H.G., Jung I.K., Kim S.H., Lee M.S. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology 2007, 32:385-391.
17. Mai J.K., Paxinos G., Voss T. Atlas of the Human Brain 2008, Elsevier, Oxford, UK. 3rd ed.
18. Moore L., Kyaw M., Vercammen A., Lenroot R., Kulkarni J., Curtis J., O'Donnell M., Carr V.J., Shannon Weickert C., Weickert T.W. Serum testosterone levels are related to cognitive function in men with schizophrenia. Psychoneuroendocrinology 2013, 38:1717-1728.
19. Morris R.W., Fung S.J., Rothmond D.A., Richards B., Ward S., Noble P.L., Woodward R.A., Weickert C.S., Winslow J.T. The effect of gonadectomy on prepulse inhibition and fear-potentiated startle in adolescent rhesus macaques. Psychoneuroendocrinology 2010, 35:896-905.
20. Morris R.W., Vercammen A., Lenroot R., Langton J.M., Short B., Kulkarni J., Curtis J., O'Donnell M., Shannon Weickert C., Weickert T.W. Disambiguating ventral striatum fMRI related BOLD signal during reward prediction in schizophrenia. Mol. Psychiatry 2012, 12:280-289.
21. Morris R.W., Quail S., Griffiths K.R., Green M.J., Balleine B.W. Corticostriatal control of goal-directed action is impaired in schizophrenia. Biol. Psychiatry 2014, 10.1016/j.biopsych.2014.06.005.
22. Niv Y., Schoenbaum G. Dialogues on prediction errors. Trends Cogn. Sci. 2008, 12:265-272.
23. Perez S.E., Chen E.Y., Mufson E.J. Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Brain Res. Dev. Brain Res. 2003, 145:117-139.
24. Pessiglione M., Seymour B., Flandin G., Dolan R.J., Frith C.D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006, 442:1042-1045.
25. Purves-Tyson T.D., Handelsman D.J., Double K.L., Owens S.J., Bustamante S., Weickert C.S. Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra. BMC Neurosci. 2012, 13:95.
26. Purves-Tyson T.D., Owens S.J., Double K.L., Desai R., Handelsman D.J., Weickert C.S. Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway. PLoS One 2014, 9:e91151.
27. Richards A.B., Morris R.W., Ward S., Schmitz S., Rothmond D.A., Noble P.L., Woodward R.A., Winslow J.T., Weickert C.S. Gonadectomy negatively impacts social behavior of adolescent male primates. Horm. Behav. 2009, 56:140-148.
28. Schlagenhauf F., Juckel G., Koslowski M., Kahnt T., Knutson B., Dembler T., Kienast T., Gallinat J., Wrase J., Heinz A. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology 2008, 196:673-684.
29. Schultz W. Updating dopamine reward signals. Curr. Opin. Neurobiol. 2013, 23:229-238.
30. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
31. Seeman P., Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol. Psychiatry 1998, 3:123-134.
32. Seeman P., Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am. J. Psychiatry 1999, 156:876-884.
33. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 1997, 388:507-525.
34. Sinclair D., Purves-Tyson T.D., Allen K.M., Weickert C.S. Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain. Psychopharmacology 2014, 231:1581-1599.
35. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
36. Taherianfard M., Shariaty M. Evaluation of serum steroid hormones in schizophrenic patients. Indian J. Med. Sci. 2004, 58:3-9.
37. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002, 15:273-289.
38. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999, 84:3666-3672.
39. Wechsler D. Wechsler Adult Intelligence Scale 1997, The Psychological Corporation, San Antonio, Texas. 3rd ed.
40. Wechsler D. Wechsler Test of Adult Reading 2001, The Psychological Corporation, San Antonio, Texas.
41. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., Straub R.E., Weinberger D.R., Kleinman J.E. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum. Mol. Genet. 2008, 17:2293-2309.
42. Weickert C.S., Sheedy D., Rothmond D.A., Dedova I., Fung S., Garrick T., Wong J., Harding A.J., Sivagnanansundaram S., Hunt C., Duncan C., Sundqvist N., Tsai S.Y., Anand J., Draganic D., Harper C. Selection of reference gene expression in a schizophrenia brain cohort. Aust. N. Z. J. Psychiatry 2010, 44:59-70.